Haiwen's life science & healthcare practice, being supported by Haiwen's fully integrated partnership platform, has an exceptionallyexperienced team to provide innovative and business savvy solutions based on its deep understanding of the industry. Haiwen's life science & healthcare team, combining itscorporate, IP and regulatory capabilities, can deliver well-rounded and value-added services to all types of clients in the life science & healthcare sector.
· We routinely advise pharmaceutical, biotechnology, medical device, cosmetics, health food and other healthcare and medtech clients on a wide variety of regulatory matters arising from the entire product life cycle, including regulatory issues concerning clinical and non-clinical research, product development, commercialization and market access strategies.
· We advise on all aspects of investment and M&A transactions, financing, banking, restructuring, IP licensing and collaboration arrangements and other complex commercial arrangements involving life sciences and healthcare companies.
· We provide tailored and seamless legal solutions on all kinds of digitalized medical or health-care services, including advising on data privacy, cybersecurity and bio-safety issues associated with transmission and processing of medical data, health data and patient data.
· We help all types of life science & healthcare companies establish and implement compliance programs, conduct internal investigations and respond to inspections initiated by regulatory authorities such as Chinese National Medical Products Administration, Chinese Market Administration of Market Regulation and Chinese Human Genetic Resources Administration Office.
· We assist all types of life science & healthcare companies in issuance and listing of stocks (depositary receipts) in China and overseas, domestic and overseas bond issuance and other securities-related services.
· We advise all types of life science & healthcare companies on anti-trust and competition matters, anti-corruption compliance, tax, employment and labor legal issues, and regularly help life science clients prevent, defend and resolve all types of disputes.
Beijing ICP No. 05019364-1 Beijing Public Network Security 110105011258
近日,北京市海问律师事务所(“本所”)发现,网络上存在将一家名为“广州海问睿律咨询顾问有限公司”的主体与本所进行不当关联的大量不实信息,导致社会公众产生混淆与误解,也对本所的声誉及正常执业活动造成不良影响。
本所特此澄清,本所与“广州海问睿律咨询顾问有限公司”(成立于2025年11月)不存在任何隶属、投资、关联、合作、授权或品牌许可关系,亦从未授权任何主体以“海问”的名义提供法律咨询服务,该公司的任何行为与本所无关。
本所的官方信息、业务领域及律师团队介绍,均应以本所官方网站(www.haiwen-law.com)及官方认证的社交媒体账号(公众号名称“海问律师事务所”)发布为准。敬请广大客户、合作伙伴及社会公众通过本所官方渠道核实信息,审慎辨别,避免因信息不实而遭受损失。
对于任何侵害本所合法权益的行为,本所特此保留追究相关方法律责任的一切权利。
特此声明。
北京市海问律师事务所
2026年1月12日